Prime Multi-Speciality Healthcare And Research Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 05-07-2024
- Paid Up Capital ₹ 2.61 Cr
as on 05-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.39 Cr
as on 05-07-2024
- Revenue %
(FY 2023)
- Profit 46.43%
(FY 2023)
- Ebitda 56.10%
(FY 2023)
- Net Worth -0.83%
(FY 2023)
- Total Assets 0.04%
(FY 2023)
About Prime Multi-Speciality Healthcare And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.61 Cr.
The company currently has active open charges totaling ₹3.90 M.
Lalit Makhija, Rahul Chhabra, Sanat Jain, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110CT2010PTC021956
- Company No.
021956
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Bilaspur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prime Multi-Speciality Healthcare And Research?
Executive Team (1)
Nitin Juneja
Managing DirectorAppointment Date: 20-Jul-2010
Status: Current
Board Members(4)
Financial Performance and Corporate Structure Insights of Prime Multi-Speciality Healthcare And Research.
Prime Multi-Speciality Healthcare And Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.43% increase in profit. The company's net worth dipped by a decrease of 0.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Multi-Speciality Healthcare And Research?
In 2023, Prime Multi-Speciality Healthcare And Research had a promoter holding of 52.33% and a public holding of 47.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
11 years 2 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 15 Mar 2012 | ₹3.90 M | Open |
How Many Employees Work at Prime Multi-Speciality Healthcare And Research?
Unlock and access historical data on people associated with Prime Multi-Speciality Healthcare And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 20, 2021, Prime Multi-Speciality Healthcare And Research has raised a total of ₹ 4.18 Cr, with the most recent deal valued at ₹ 1.33 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
